Global Clinical Trial Supplies Market
Clinical trial supplies are defined as various tools & equipments which are used for conducting scientific experiments, investigations & clinical research. nebulizers &syringe needles as well as Infusion pumps are the most commonly used clinical trial supplies. They are mainly used for conducting medical trials for detecting, preventing & treating various ailments, analysing the efficiency of a treatment method, & in the diagnosis of various infectious as well as metabolic disorders. They also find extensive applications during oncological, respiratory, cardiovascular and neurological procedures.
Market Drivers
Significant growth in biopharmaceutical industry is one of the prominent factors driving the global clinical trial supplies market growth. Clinical Trials gaining traction for treating diseases including HIV and cancer, with the development of innovation drug delivery systems. Also, the increase in number of clinical trials is expected to boost the global clinical trial supplies market growth over the forecast period. For instance, according to ClinicalTrials.gov information, as of May 2017, the United States accounted for 36% of clinical trials & around 245,188 studies were registered with ClinicalTrials.gov.
Furthermore, the rise in adoption of supply chain management system is due to increasing pressure to cut down research and development cost & improve the operational efficiency as the supplies contribute significantly to the total research and development expense of biopharmaceutical companies. To cut down the cost of supplies, biopharmaceutical companies are outsourcing their supplies to global as well as regional supply players, which helps them to focus on the clinical trial process. The geographical distribution of clinical Trials is slowly shifting from developed countries to emerging countries> the increasing cost & difficulty in patient recruitment have led biopharmaceutical companies to shift towards regions including Europe, Asia Pacific, Latin America, and Middle East for cost efficiency & quick patient recruitment.
Market Restraints
The increase in cost of drug development and clinical trials is the major restraint which hamper the global clinical trial supplies market growth. Also, the stringent regulatory guidelines for development of drug delivery systems are expected to restraint the growth of clinical trial supplies market.
Market Segmentation
The Global Clinical Trial Supplies Market is segmented into Clinical Phase Type such as Phase I, Phase II, Phase III, and Other. The Phase I is anticipated to be the fastest growing segment owing to the increase in number of outsourced Phase I trials. Lesser sample population & high capital investment are the important factors responsible for outsourcing the major volume of clinical trials.
Further, market is segmented into product & services including Manufacturing, Storage & Distribution, and Supply Chain Management. Based on the product & services segment is expected to be fastest growing segment, due to the increase in number of outsourced storage & distribution facility. On the basis of end use market is segmented into Pharmaceuticals, Biologics, Medical Device, and Others.
Based on the therapeutic use market is segmented into Oncology, CNS, Infectious disease, Cardiovascular, Metabolic disorders, and Others. Oncology is estimated to register for the largest revenue share of the overall clinical trials supplies market, due to the increase in cancer care therapeutics and the execution of clinical trials for the design, execution, and patient identification of these therapies fuel the demand for clinical supplies to be used in cancer therapies.
Regional Analysis
The Global Clinical Trial Supplies Market is segmented into five regions such as North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.
The North America is the leading contributor to the global clinical trial supplies market growth followed by Europe. Due to the high share of clinical trials conducted in this region & greater number of clinical trial supply players with the most advanced technology. Also, APAC is anticipated to witness the fastest growth due to its diverse population, easy access to patients, proximity to North America, & low translation cost. Latin America & Middle East and Africa are also expected to witness significant growth due to the rise in number of clinical trials conducted in this region.
Key Players
Several key players are discussed in global clinical trial supplies market including, Thermo Fischer Scientific, Sharp Packaging Services, Patheon Inc., Biocair International Ltd., Almac Group Ltd, PAREXEL International Corporation, KLIFO A/S, Catalent Pharma Solutions, Inc., PCI Pharma Distribution, Movianto, etc. The number of new companies trying to enter into the healthcare industry will positively influence the market growth. Moreover, expansion of geographic presence & development of niche business units catering to the healthcare industry are being currently performed by various players. For instance, in July 2015, Almac Group expanded its supply facility in the Singapore.
Market Taxonomy
By Clinical Phase Type
By Product & Services
By End Use
By Therapeutic Use
By Region
Key Questions Addressed by the Report
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Clinical Trial Supplies Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Clinical Trial Supplies Market, By Clinical Phase Type
5.1 Y-o-Y Growth Comparison, By Clinical Phase Type
5.2 Global Clinical Trial Supplies Market Share Analysis, By Clinical Phase Type
5.3 Global Clinical Trial Supplies Market Size and Forecast, By Clinical Phase Type
5.3.1 Phase I
5.3.2 Phase II
5.3.3 Phase III
5.3.4 Others
6 Global Clinical Trial Supplies Market, By Product & Service
6.1 Y-o-Y Growth Comparison, By Product & Service
6.2 Global Clinical Trial Supplies Market Share Analysis, By Product & Service
6.3 Global Clinical Trial Supplies Market Size and Forecast, By Product & Service
6.3.1 Manufacturing
6.3.2 Storage & Distribution
6.3.3. Supply Chain Management
7 Global Clinical Trial Supplies Market, By End Use
7.1 Y-o-Y Growth Comparison, By End Use
7.2 Global Clinical Trial Supplies Market Share Analysis, By End Use
7.3 Global Clinical Trial Supplies Market Size and Forecast, By End Use
7.3.1 Pharmaceuticals
7.3.2 Biologics
7.3.3 Medical device
7.3.4. Others
8 Global Clinical Trial Supplies Market, By Therapeutic Use
8.1 Y-o-Y Growth Comparison, By Therapeutic Use
8.2 Global Clinical Trial Supplies Market Share Analysis, By Therapeutic Use
8.3 Global Clinical Trial Supplies Market Size and Forecast, By Therapeutic Use
8.3.1 Oncology
8.3.2 CNS
8.3.3 Infectious disease
8.3.4 Cardiovascular
8.3.5 Metabolic disorders
8.3.6. Others
9Global Clinical Trial Supplies Market, By Region
9.1 Global Clinical Trial Supplies Market Share Analysis, By Region
9.2 Global Clinical Trial Supplies Market Share Analysis, By Region
9.3 Global Clinical Trial Supplies Market Size and Forecast, By Region
10 North America Clinical Trial Supplies Analysis and Forecast (2020 – 2030)
10.1 Introduction
10.2 North America Clinical Trial Supplies Product Market Share Analysis, By Clinical Phase Type
10.3 North America Clinical Trial Supplies Product Market Size and Forecast, By Product & Service
10.4 North America Clinical Trial Supplies Product Market Size and Forecast, By End Use
10.5 North America Clinical Trial Supplies Product Market Size and Forecast, By Therapeutic Use
10.6 North America Clinical Trial Supplies Product Market Size and Forecast, By Country
10.6.1 U.S.
10.6.2 Canada
10.6.3 Mexico
11Europe Clinical Trial Supplies Market Analysis and Forecast (2020 – 2030)
11.1 Introduction
11.2 Europe Clinical Trial Supplies Product Market Share Analysis, By Clinical Phase Type
11.3 Europe Clinical Trial Supplies Product Market Size and Forecast, By Product & Service
11.4 Europe Clinical Trial Supplies Product Market Size and Forecast, By End Use
11.5 Europe Clinical Trial Supplies Product Market Size and Forecast, By Therapeutic Use
11.6 Europe Clinical Trial Supplies Product Market Size and Forecast, By Country
11.6.1 Germany
11.6.2 France
11.6.3 UK
11.64. Rest of Europe
12Asia Pacific Clinical Trial Supplies Market Analysis and Forecast (2020 – 2030)
12.1 Introduction
12.2 Asia Pacific Clinical Trial Supplies Product Market Share Analysis, By Clinical Phase Type
12.3 Asia Pacific Clinical Trial Supplies Product Market Size and Forecast, By Product & Service
12.4 Asia Pacific Clinical Trial Supplies Product Market Size and Forecast, By End Use
12.5 Asia Pacific Clinical Trial Supplies Product Market Size and Forecast, By Therapeutic Use
12.6 Asia Pacific Clinical Trial Supplies Product Market Size and Forecast, By Country
12.6.1 China
12.6.2 Japan
12.6.3 India
12.6.4. Rest of Asia Pacific
13Latin America Clinical Trial Supplies Market Analysis and Forecast (2020 – 2030)
13.1 Introduction
13.2 Latin America Clinical Trial Supplies Product Market Share Analysis, By Clinical Phase Type
13.3 Latin America Clinical Trial Supplies Product Market Size and Forecast, By Product & Service
13.4 Latin America Clinical Trial Supplies Product Market Size and Forecast, By End Use
13.5 Latin America Clinical Trial Supplies Product Market Size and Forecast, By Therapeutic Use
13.6 Latin America Clinical Trial Supplies Product Market Size and Forecast, By Country
14Middle East Clinical Trial Supplies Market Analysis and Forecast (2020 – 2030)
14.1 Introduction
14.2 Middle East Clinical Trial Supplies Product Market Share Analysis, By Clinical Phase Type
14.3 Middle East Clinical Trial Supplies Product Market Size and Forecast, By Product & Service
14.4 Middle East Clinical Trial Supplies Product Market Size and Forecast, By End Use
14.5 Middle East Clinical Trial Supplies Product Market Size and Forecast, By Therapeutic Use
14.6 Middle East Clinical Trial Supplies Product Market Size and Forecast, By Country
15Competitive Analysis
15.1 Competition Dashboard
15.2 Market share Analysis of Top Vendors
15.3 Key Development Strategies
16Company Profiles
16.1 Thermo Fischer Scientific
16.1.1 Overview
16.1.2 Offerings
16.1.3 Key Financials
16.1.4 Business Segment & Geographic Overview
16.1.5 Key Market Developments
16.1.6 Key Strategies
16.2 Sharp Packaging Services
16.2.1 Overview
16.2.2 Offerings
16.2.3 Key Financials
16.2.4 Business Segment & Geographic Overview
16.2.5 Key Market Developments
16.2.6 Key Strategies
16.3 Patheon Inc
16.3.1 Overview
16.3.2 Offerings
16.3.3 Key Financials
16.3.4 Business Segment & Geographic Overview
16.3.5 Key Market Developments
16.3.6 Key Strategies
16.4 Biocair International Ltd
16.4.1 Overview
16.4.2 Offerings
16.4.3 Key Financials
16.4.4 Business Segment & Geographic Overview
16.4.5 Key Market Developments
16.4.6 Key Strategies
16.5 Almac Group Ltd
16.5.1 Overview
16.5.2 Offerings
16.5.3 Key Financials
16.5.4 Business Segment & Geographic Overview
16.5.5 Key Market Developments
16.5.6 Key Strategies
16.6 PAREXEL International Corporation
16.6.1 Overview
16.6.2 Offerings
16.6.3 Key Financials
16.6.4 Business Segment & Geographic Overview
16.6.5 Key Market Developments
16.6.6 Key Strategies
16.7 KLIFO A/S
16.7.1 Overview
16.7.2 Offerings
16.7.3 Key Financials
16.7.4 Business Segment & Geographic Overview
16.7.5 Key Market Developments
16.7.6 Key Strategies
16.8 Catalent Pharma Solutions, Inc
16.8.1 Overview
16.8.2 Offerings
16.8.3 Key Financials
16.8.4 Business Segment & Geographic Overview
16.8.5 Key Market Developments
16.8.6 Key Strategies
16.9 PCI Pharma Distribution
16.9.1 Overview
16.9.2 Offerings
16.9.3 Key Financials
16.9.4 Business Segment & Geographic Overview
16.9.5 Key Market Developments
16.9.6 Key Strategies
16.10 Movianto
16.10.1 Overview
16.10.2 Offerings
16.10.3 Key Financials
16.10.4 Business Segment & Geographic Overview
16.10.5 Key Market Developments
16.10.6 Key Strategies
